KS

Kamani Satish Somavanshi

Active Director Director DIN 10406319
DIN 10406319 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamani Satish Somavanshi

Data last updated:

Kamani Satish Somavanshi is a Director at Akrivis Lifescience Private Limited (since 2023). The company operates in Pharma.

DIN 10406319
Primary Designation Director
Industry Pharma
First Appointment 28 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akrivis Lifescience Private Limited U47721MH2023PTC414466
Director28 Nov 20232023Active

Board colleagues of Kamani Satish Somavanshi

NameDINCompanyDesignation
Maithili Vijay Indargi11458734Akrivis Lifescience Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Akrivis Lifescience Private Limited
Premium access

Shareholding and investment profile for Kamani Satish Somavanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamani Satish Somavanshi

Kamani Satish Somavanshi currently holds 1 directorship: Akrivis Lifescience Private Limited (Director, since 28 Nov 2023).

Kamani Satish Somavanshi was first appointed on 28 Nov 2023 as Director at Akrivis Lifescience Private Limited.

The current boards of Kamani Satish Somavanshi's companies include Maithili Vijay Indargi (Akrivis Lifescience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available